Search results
5 days ago · For now, XPRIZE founder Peter Diamandis, a physician who writes about longevity, says he takes rapamycin. “I do six milligrams every Sunday night, so once a week," for three months, he explains.
5 days ago · Now a dentist is testing if rapamycin stops gum disease — a canary in the coal mine for age-related diseases. A few years back, Matt Kaeberlein was diagnosed with a frozen shoulder. “It was really bad,” he recalls. He wasn’t sleeping well and couldn’t throw a ball due to the pain. His doctor recommended physical therapy, and told him ...
5 days ago · Longevity researchers are taking a generic drug they think may help extend people's lives. Now a dentist is testing if rapamycin stops gum disease — a canary in the coal mine for age-related diseases.
3 days ago · A page of Peter’s Passport. So, after ten months of traveling, Peter could not afford to proceed to Australia as initially planned. He went back to Canada, where he could legally work as a British citizen, in order to replenish his funds. Bearing North, Peter hitchhiked 5,000 miles in just 10 days.
5 days ago · Michael Chernow is a restaurateur, entrepreneur, and the founder of Kreatures of Habit. <br /><br />This conversation explores Michael’s cinematic journey of sobriety, resilience, and redemption. We discuss his traumatic childhood, the depths of his addiction, the heights of culinary success, and how fitness and recovery eclipsed a life beyond his dreams. Michael emphasizes the power of ...
2 days ago · ABOUT THIS PODCAST 🔗. Impact Theory is committed to an unbiased pursuit of the truth. Tom Bilyeu approaches the most important issues in world affairs, finance, AI and Future tech, politics and mindset by breaking down these complex topics into their fundamental elements.
5 days ago · Cirrus Therapeutics, the University of Bristol, and London’s Global University Institute of Ophthalmology have discovered a new treatment for age-related macular degeneration (AMD), the leading cause of vision loss among older adults.
